HOMOLEPTIC RARE EARTH TRIARYL COMPLEXES
    2.
    发明申请
    HOMOLEPTIC RARE EARTH TRIARYL COMPLEXES 审中-公开
    HOMOLEPTIC RARE EARTH TRIARYL复合材料

    公开(公告)号:US20140155562A1

    公开(公告)日:2014-06-05

    申请号:US14235285

    申请日:2012-08-02

    摘要: The invention relates to chelate-stabilized homleptic triaryl compounds based on phenylphosphoranes, to methods for preparing same and to the use thereof as catalysts. According to the invention, the object is achieved by homleptic rare earth triaryl complexes of the general formula (I), where SE=Sc, Y, La, Ce, Pr, Nd, Pm, Sm, Eu, Gd, Tb, Dy, Ho, Er, Tm, Yb or Lu; X=O, CRR′; R1, R2=phenyl; R, R′=mutually independently H, alkyl with n=10 C atoms, phenyl or trimethylsilyl.

    摘要翻译: 本发明涉及基于苯基磷烷的螯合稳定的亲和三芳基化合物,其制备方法及其作为催化剂的用途。 根据本发明,该目的通过通式(I)的亲水性稀土三芳基络合物实现,其中SE = Sc,Y,La,Ce,Pr,Nd,Pm,Sm,Eu,Gd,Tb,Dy, Ho,Er,Tm,Yb或Lu; X = O,CRR'; R1,R2 =苯基; R,R'=相互独立地为H,具有n = 10个C原子的烷基,苯基或三甲基甲硅烷基。

    Ortho-metalated, chelate-stabilized benzylamines of the rare-earth metals (RE) Ar3RE
    3.
    发明申请
    Ortho-metalated, chelate-stabilized benzylamines of the rare-earth metals (RE) Ar3RE 审中-公开
    稀土金属(RE)Ar3RE的正金属化,螯合稳定的苄胺

    公开(公告)号:US20110034713A1

    公开(公告)日:2011-02-10

    申请号:US12745057

    申请日:2008-11-25

    IPC分类号: C07F5/00

    CPC分类号: C07D207/06 C07F3/00

    摘要: The present invention describes homoleptic, ortho-metalated, chelate-stabilized benzylamine complexes of the rare-earth metals. The rare-earth metals are selected from Sc, Y, La, Ce, Pr, Nd, Pm, Sm, Eu, Gd, Tb, Dy, Ho, Er, Tm, Yb, Lu. In the complexes according to the present invention, at least one benzylic proton of the benzylamine ligand is replaced by an alkyl or aryl group. Such complexes are preferred in which both benzylic protons of the benzylamine ligand are replaced by an alkyl- or aryl group. The complexes according to the present invention are produced by reaction of chelate-stabilized rare-earth metal halides with ortho-lithiated aryl ligands at room temperature under inert gas atmosphere. The complexes according to the present invention are thermally stable and suitable for being used as catalysts for the hydroamination of olefins.

    摘要翻译: 本发明描述了稀土金属的均聚,邻位金属化,螯合稳定的苄胺络合物。 稀土金属选自Sc,Y,La,Ce,Pr,Nd,Pm,Sm,Eu,Gd,Tb,Dy,Ho,Er,Tm,Yb,Lu。 在根据本发明的络合物中,苄胺配体的至少一个苄基质子被烷基或芳基取代。 这种络合物是优选的,其中苄胺配体的两个苄基质子都被烷基或芳基取代。 根据本发明的络合物通过螯合稳定的稀土金属卤化物与邻位锂化的芳基配体在室温下在惰性气体气氛下反应来制备。 根据本发明的络合物是热稳定的并且适用于用作烯烃的水解的催化剂。

    CYCLOPENTADIENYLIDENE-PHOSPHORANE CONSTRAINED GEOMETRY COMPLEXES OF RARE EARTH METALS
    7.
    发明申请
    CYCLOPENTADIENYLIDENE-PHOSPHORANE CONSTRAINED GEOMETRY COMPLEXES OF RARE EARTH METALS 审中-公开
    稀土金属的环烯二烯基磷光体约束几何复合物

    公开(公告)号:US20140163187A1

    公开(公告)日:2014-06-12

    申请号:US14235259

    申请日:2012-08-02

    IPC分类号: C08F4/52 C08G63/84 C07F9/54

    摘要: The invention relates to η5:η1-cyclopentadienylidene-phosphorane constrained geometry complexes of rare earth metals, abbreviated to η5:η1-CpPC-CGC, method for production and use of same. The η5:η1-CpPC-CGCs correspond to the general formula (1), wherein SE=Sc, Y, La, Ce, Pr, Nd, Pm, Sm, Eu, Gd, Tb, Dy, Ho, Er, Tm, Yb or Lu; X=independently of one another, a mono-anionic diorganoamido-, bistrimethylsilylamido-, halogenido-, alkyl-, aryl-, alkoxo-, aryloxo- or alkylaluminate (AlR4−) substituent; L=neutral ligand (PR3, NR3, pyridine), solvent molecule (THF, ether, DMF, DMSO, HMPT, tetrahydropyran THP, tetrahydrothiofuran THT); R=alkyl with up to 1-10 C atoms or mono- or polycyclical aryl with 6 to 20 C atoms; R1, R4=independently of one another H or methyl; R2, R3=independently of one another, H or methyl or tertiary butyl or together a substituted cycloalkyl group; R5, R6=methyl, n-butyl, tertiary butyl or phenyl; R7, R8=independently of one another H, trimethylsilyl, alkyl with 1-10 C atoms or mono- or polycyclical aryl with 6 to 20 C atoms, and m=0, 1, 2 or 3.

    摘要翻译: 本发明涉及& 5>稀土金属的1-环戊二烯基 - 正磷烷约束几何配合物,缩写为& e> 1-CpPC-CGC,其生产和使用方法。 其中SE = Sc,Y,La,Ce,Pr,Nd,Pm,Sm,Eu,Gd,Tb,Dy,Ho等于通式(1) Er,Tm,Yb或Lu; X =彼此独立,单阴离子二有机基酰胺基,双三甲基甲硅烷基氨基 - ,卤代 - ,烷基 - ,芳基 - ,烷氧基 - ,芳氧基 - 或烷基铝酸盐(AlR 4 - )取代基; L =中性配体(PR3,NR3,吡啶),溶剂分子(THF,醚,DMF,DMSO,HMPT,四氢吡喃THP,四氢噻呋喃THT); R =具有至多1-10个C原子的烷基或具有6至20个C原子的单环或多环芳基; R1,R4 =彼此独立地为H或甲基; R2,R3彼此独立地为H或甲基或叔丁基或一起取代的环烷基; R 5,R 6 =甲基,正丁基,叔丁基或苯基; R 7,R 8彼此独立地为H,三甲基甲硅烷基,具有1-10个C原子的烷基或具有6至20个C原子的单环或多环芳基,m = 0,1,2或3。